• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际干细胞库协会(ISCBI)。

The International Stem Cell Banking Initiative (ISCBI).

机构信息

International Stem Cell Banking Initiative, 2 High Street, Barley, UK; National Stem Cell Resource Centre, Institute of Zoology, Chinese Academy of Sciences, Beijing 100190, China; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China.

Francis Crick Institute, 1 Midland Road, London, UK.

出版信息

Stem Cell Res. 2021 May;53:102265. doi: 10.1016/j.scr.2021.102265. Epub 2021 Feb 22.

DOI:10.1016/j.scr.2021.102265
PMID:33799275
Abstract

The International Stem Cell Banking Initiative(ISCBI) was started in 2007 to bring together the leading stem cell banks distributing human pluripotent stem cell (hPSC) lines for research and development, to discuss best practice across a range of issues from donor consent to delivery of cells for use in research, diagnostics and cell-based medicines. ISCBI holds workshops around the world and on-line and regularly publishes summaries of discussions and consensus amongst experts in stem cell biology, biobanking technology, regulation and policy making. To date, experts from more than 28 countries have contributed to ISCBI activities which are frequently run in collaboration with other stem cell organisations and has co-ordinated closely with the International Stem Cell Initiative and the hPSCreg European Commission funded database of hPSC lines and clincal trials.

摘要

国际干细胞库协会(ISCBI)成立于 2007 年,旨在汇集领先的干细胞库,为研究和开发分发人类多能干细胞(hPSC)系,讨论从供体同意到用于研究、诊断和基于细胞的药物的细胞交付等一系列问题的最佳实践。ISCBI 在全球范围内举办研讨会,并在线定期发布干细胞生物学、生物库技术、监管和决策制定方面专家讨论和共识的摘要。迄今为止,来自 28 个以上国家的专家为 ISCBI 的活动做出了贡献,这些活动经常与其他干细胞组织合作,并与国际干细胞倡议和欧洲委员会资助的 hPSC 系和临床试验 hPSCreg 数据库密切协调。

相似文献

1
The International Stem Cell Banking Initiative (ISCBI).国际干细胞库协会(ISCBI)。
Stem Cell Res. 2021 May;53:102265. doi: 10.1016/j.scr.2021.102265. Epub 2021 Feb 22.
2
Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells.国际干细胞库倡议研讨会活动报告:人类多能干细胞种子库存储的当前障碍和进展。
Stem Cells Transl Med. 2017 Nov;6(11):1956-1962. doi: 10.1002/sctm.17-0144. Epub 2017 Oct 24.
3
Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI).用于临床应用的多能干细胞种子库开发中需考虑的要点:国际干细胞库倡议组织(ISCBI)。
Regen Med. 2015;10(2 Suppl):1-44. doi: 10.2217/rme.14.93.
4
Biobanking of human pluripotent stem cells in China.中国人类多能干细胞的生物样本库。
Cell Prolif. 2022 Jul;55(7):e13180. doi: 10.1111/cpr.13180. Epub 2022 Jun 2.
5
The International Stem Cell Banking Initiative (ISCBI): raising standards to bank on.国际干细胞库协会(ISCBI):提高标准,为存储而努力。
In Vitro Cell Dev Biol Anim. 2010 Apr;46(3-4):169-72. doi: 10.1007/s11626-010-9301-7. Epub 2010 Mar 3.
6
Governing stem cell banks and registries: emerging issues.管理干细胞库和登记处:新出现的问题。
Stem Cell Res. 2009 Sep-Nov;3(2-3):96-105. doi: 10.1016/j.scr.2009.05.003. Epub 2009 May 25.
7
A Standard Nomenclature for Referencing and Authentication of Pluripotent Stem Cells.人多能干细胞命名和鉴定的标准化命名法。
Stem Cell Reports. 2018 Jan 9;10(1):1-6. doi: 10.1016/j.stemcr.2017.12.002.
8
A Report from a Workshop of the International Stem Cell Banking Initiative, Held in Collaboration of Global Alliance for iPSC Therapies and the Harvard Stem Cell Institute, Boston, 2017.国际干细胞库倡议研讨会报告,由全球诱导多能干细胞治疗联盟与哈佛干细胞研究所联合主办,2017 年于波士顿召开。
Stem Cells. 2019 Sep;37(9):1130-1135. doi: 10.1002/stem.3003. Epub 2019 Aug 6.
9
Identification and Re-consent of Existing Cord Blood Donors for Creation of Induced Pluripotent Stem Cell Lines for Potential Clinical Applications.鉴定和重新同意现有的脐带血捐献者,以创建潜在临床应用的诱导多能干细胞系。
Stem Cells Transl Med. 2022 Oct 21;11(10):1052-1060. doi: 10.1093/stcltm/szac060.
10
Biobanking human embryonic stem cell lines: policy, ethics and efficiency.人类胚胎干细胞系生物样本库:政策、伦理与效率
Monash Bioeth Rev. 2015 Dec;33(4):265-76. doi: 10.1007/s40592-015-0050-y.

引用本文的文献

1
Promoting the adoption of best practices and standards to enhance quality and reproducibility of stem cell research.推广采用最佳实践和标准,以提高干细胞研究的质量和可重复性。
Stem Cell Reports. 2025 Jul 8;20(7):102531. doi: 10.1016/j.stemcr.2025.102531. Epub 2025 Jun 12.
2
Comparative analysis of regulations and studies on stem cell therapies: focusing on induced pluripotent stem cell (iPSC)-based treatments.比较分析干细胞疗法的法规和研究:重点关注基于诱导多能干细胞(iPSC)的治疗方法。
Stem Cell Res Ther. 2024 Nov 21;15(1):447. doi: 10.1186/s13287-024-04065-9.
3
Exploring stem cell frontiers: definitions, challenges, and perspectives for regenerative medicine.
探索干细胞前沿:再生医学的定义、挑战和展望。
Biol Open. 2024 Apr 15;13(4). doi: 10.1242/bio.060245. Epub 2024 Apr 9.
4
ISSCR standards for the use of human stem cells in basic research.国际干细胞研究学会人类干细胞基础研究使用标准。
Stem Cell Reports. 2023 Sep 12;18(9):1744-1752. doi: 10.1016/j.stemcr.2023.08.003.
5
Country-specific regulation and international standardization of cell-based therapeutic products derived from pluripotent stem cells.基于多能干细胞的细胞治疗产品的国家特定法规和国际标准化。
Stem Cell Reports. 2023 Aug 8;18(8):1573-1591. doi: 10.1016/j.stemcr.2023.05.003.